Clinical and pharmacological group: & nbsp

Other non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs

Included in the formulation
  • Abisil
    solution locally externally 
    INITIUM-PHARM     Russia
  • АТХ:

    D.06.B.X   Other antimicrobials

    Pharmacodynamics:

    The drug has a pronounced anti-inflammatory, wound-healing, antibacterial, analgesic, antiexudative action, caused by the properties of natural terpenoids that make up its composition. Has a wide spectrum of antimicrobial activity against Gram-positive and Gram-negative bacteria, including antibiotic-resistant strains. Creates optimal conditions for healing the wound surface of soft tissues, accelerates the process of epithelization, improves microcirculation.

    When topical application is not absorbed and does not have a local irritant effect. The drug has no toxic properties, teratogenic, mutagenic and carcinogenic effects have not been identified, which allows it to be used in all age groups

    Pharmacokinetics:

    Not described.

    Indications:

    In surgery: purulent-inflammatory diseases of the skin and soft tissues (wounds, burns, frostbites, ulcers, pressure sores, abscess, phlegmon, including the maxillofacial area).

    In dentistry: stomatitis, periodontitis, complications in prosthetics of teeth.

    In otorhinolaryngology: purulent-inflammatory diseases of the ear, throat, nose and paranasal sinuses.

    In dermatology: Bullous-necrotic forms of erysipelas, pyoderma.

    X.J00-J06.J04   Acute laryngitis and tracheitis

    X.J00-J06.J03   Acute tonsillitis

    X.J00-J06.J02   Acute pharyngitis

    X.J00-J06.J01   Acute Sinusitis

    X.J30-J39.J37   Chronic laryngitis and laryngotracheitis

    X.J30-J39.J35.0   Chronic tonsillitis

    X.J30-J39.J32   Chronic Sinusitis

    X.J30-J39.J31   Chronic rhinitis, nasopharyngitis and pharyngitis

    I.A30-A49.A46   Erys

    VIII.H65-H75.H66   Purulent and unspecified otitis media

    VIII.H65-H75.H68   Inflammation and occlusion of the auditory [Eustachian] tube

    IX.I80-I89.I83.2   Varicose veins of the lower extremities with ulcer and inflammation

    XI.K00-K14.K05   Gingivitis and periodontal disease

    XI.K00-K14.K12   Stomatitis and related lesions

    XII.L00-L08.L01   Impetigo

    XII.L00-L08.L02   Abscess of skin, boil and carbuncle

    XII.L00-L08.L03   Phlegmon

    XII.L00-L08.L08.0   Pyoderma

    XIX.T33-T35.T33   Surface frostbite

    XIX.T79.T79.3   Post-traumatic wound infection, not elsewhere classified

    Contraindications:

    Hypersensitivity, individual intolerance.

    Carefully:

    No data.

    Pregnancy and lactation:

    Recommendations for The FDA is not defined. Adequate controlled studies in humans have not been conducted. Do not apply.

    Dosing and Administration:

    Apply topically, externally. Shake before use!

    With purulent-inflammatory diseases of the skin and soft tissues, preliminary surgical treatment of the wound surface is carried out and then the preparation is applied 1-2 times a day with a uniform thin layer. The duration of treatment depends on the form and severity of the disease (usually 5-10 days) and ends when fresh granulations, epithelial islets or complete epithelialization appear.

    In inflammatory processes in the maxillofacial region, after opening and surgical processing of abscesses and phlegmon, tampons impregnated with the solution are injected into the pockets and postoperative wounds. The procedure is repeated daily for 5-7 days. When diseases of the oral cavity, treat the affected surface of the mucous membrane 2-3 times a day or apply turunas moistened with the drug. When otitis enter into the external ear canal a tampon moistened with the drug. When treating rhinitis, sinusitis is instilled in each nasal passage of 1-2 drops 3-4 times a day. With sinusitis, the drug is injected into the maxillary sinus after its preliminary sanitation.

    When treating tonsillitis and other inflammatory diseases of the throat, treat the preparation with mucous membranes 2-3 times a day.

    With skin diseases, the drug is applied 1-3 times a day with a thin layer on the affected areas. The duration of the course is individual and depends on the severity of the disease.

    Side effects:

    Short-term burning in the place of application. In people with hypersensitivity to essential oils, allergic reactions are possible.

    Overdose:

    Overdose is not described.

    Interaction:

    Do not combine with other external medicines.

    Special instructions:

    Before use, the vial with the drug must be shaken.

    Do not allow the product to get into the conjunctiva of the eye, if it does, rinse the eye with water.

    Do not apply to damp skin.

    Instructions
    Up